Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could your GP spot heart trouble with a handheld ultrasound?

NCT ID NCT07427303

Diagnosis Sponsor: University Hospital, Caen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study explores whether general practitioners can use a tiny ultrasound device to detect early signs of heart disease during a routine office visit. Researchers will enroll 300 adults aged 65 and older with risk factors, or adults with symptoms like shortness of breath or leg swelling. The goal is to see if GP-performed scans match expert interpretations, potentially making heart screening more accessible in areas with limited specialists.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
point-of-care ultrasound device
What this could lead to
If successful, this could allow GPs to screen for early heart failure in their office, potentially reducing hospitalizations and deaths by catching problems sooner.
What could go wrong
This is a small feasibility study, not yet recruiting. It only checks if GPs can perform and interpret the scan accurately compared to experts, so it may not prove real-world benefit or be widely adopted.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 to 120 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men and women aged 65 or older with no cardiac symptoms and presenting with a treated or untreated cardiovascular risk factor (hypertension and/or diabetes and/or dyslipidemia) or * Adult men and women presenting with one of the following signs: * Stage I-II exertional dyspnea * Lower limb edema * Unexplained fatigue * Weight gain * Unexplained cough * History of carpal tunnel surgery (search for signs of myocardial infiltration by cardiac amyloidosis) Exclusion Criteria: * Patients with arrhythmia or ventricular or supraventricular hyper excitability. * Symptomatic patients: * exertional dyspnea (NYHA \>2) * palpitations * malaise * chest pain * Obese individuals with a BMI \>35 * Patients with breast implants * Patients under guardianship, conservatorship, or legal protection * Patients without health insurance coverage or equivalent * Patients known to have heart disease * Patients who have had a cardiology consultation within the last 5 years * Subjects with known heart disease, whether monitored or not. * Known valvular heart disease (whether monitored or not) * Known coronary artery disease (whether monitored or not)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Age 65 and older are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cough Dyspnea Edema heart failure Weight Gain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Age 65 and older Cardiac risk factors Cough Dyspnea; cardiac Fatigability Oedema Weight gain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.